The patient-derived PTC and ATC cells (3.5 × 106 cells/mouse) were cultured in vitro and then injected subcutaneously into the upper left flank region of female BALB/c nude mice. After 11 days, tumor-bearing mice were assigned to groups randomly (n = 10/group) and administered 10 mg/kg lenvatinib (p.o.) and 40 mg/kg sorafenib (p.o.), either alone or in combination with 25 mg/kg HNHA (given i.p.) once every 2 days. Tumor size was measured every three day using calipers. Tumor volume was estimated using the following formula: L × S2/2 (L, longest diameter; S, shortest diameter). Animals were maintained under specific pathogen-free conditions. All experiments were approved by the Animal Experiment Committee of Yonsei University.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.